About
Roger Li is a PhD student at the Institute for Respiratory Health, Perth. He commenced his PhD with the University of Western Australia in 2021 after completing a First Class Honours in Biomedical Science in 2020.
He is seeking to understand the effects of antifibrotic drug therapy in idiopathic pulmonary fibrosis and identify predictive circulatory biomarkers and epigenetic markers.